
Glycogen Storage Disease Type I - GeneReviews® - NCBI Bookshelf
2006年4月19日 · Glycogen storage disease type I (GSD I) is characterized by accumulation of glycogen and fat in the liver and kidneys resulting in hepatomegaly and nephromegaly. Severely affected infants present in the neonatal period with severe hypoglycemia due to …
Home - Harvard Graduate School of Design
2025年2月28日 · The Graduate School of Design educates leaders in design, research, and scholarship to make a resilient, just, and beautiful world.
Dietary Management of the Glycogen Storage Diseases: Evolution of ...
We examine historic and current approaches for preventing hypoglycemia associated with GSDs. There is a lack of consensus on the optimal dietary management of GSDs despite decades of research, and the ongoing controversies are discussed.
Glycogen Storage Disease Type III - GeneReviews® - NCBI Bookshelf
2010年3月9日 · Glycogen storage disease type III (GSD III) is characterized by variable liver, cardiac muscle, and skeletal muscle involvement. GSD IIIa is the most common subtype, present in about 85% of affected individuals; it manifests with liver and muscle involvement. GSD IIIb, with liver involvement only, comprises about 15% of all affected individuals.
Glycogen Storage Disease - StatPearls - NCBI Bookshelf
2025年1月21日 · Glycogen storage diseases (GSDs) are inherited inborn errors of carbohydrate metabolism that result in abnormal glycogen storage. The onset can range from neonatal life to adulthood, and clinical manifestations result either from a failure to convert glycogen into energy or the toxic accumulation of glycogen.
Hepatic glycogen storage diseases: pathogenesis, clinical …
Glycogen storage diseases (GSDs) are genetically determined metabolic diseases that cause disorders of glycogen metabolism in the body. Due to the enzymatic defect at some stage of glycogenolysis/glycogenesis, excess glycogen or its pathologic …
Diagnosis and management of glycogen storage diseases type VI ... - PubMed
Purpose: Glycogen storage disease (GSD) types VI and IX are rare diseases of variable clinical severity affecting primarily the liver. GSD VI is caused by deficient activity of hepatic glycogen phosphorylase, an enzyme encoded by the PYGL gene.
Glycogen storage disease type III: diagnosis, genotype ... - PubMed
Glycogen storage disease type III (GSDIII) is a rare disorder of glycogenolysis due to AGL gene mutations, causing glycogen debranching enzyme deficiency and storage of limited dextrin. Patients with GSDIIIa show involvement of liver and cardiac/skeletal muscle, whereas GSDIIIb patients display only liver symptoms and signs.
Usefulness of a Digitally Assisted Person-Centered Care ... - PubMed
2023年5月18日 · The intervention was adapted into a digital version called digitally assisted guided self-determination (DA-GSD) hosted by the Sundhed DK website that can be delivered face-to-face, via video, or by the combination of the 2 methods.
Von Gierke: fatos, causas e tratamento - liverfoundation.org
A doença de armazenamento de glicogênio tipo I (GSD I), também conhecida como doença de von Gierke, é a forma mais comum de doença de armazenamento de glicogênio, sendo responsável por 25% de todos os casos. É uma doença hereditária que afeta o metabolismo - a forma como o corpo transforma os alimentos em energia.